A61P

Therapeutic Activity

USPTO Patent Grants

← All categories

97 items

Grant

Intelligent Gallery Management For Biometrics

US12579237B2 · Alclear, LLC · Mar 17, 2026
A61P G06F
Grant

Optical Sensor And Method Of Detecting An Led In Such A Sensor

US12578376B2 · Endress+Hauser Conducta GmbH+Co. KG · Mar 17, 2026
G01J G01J
Grant

Anti Lock Hinged Device

US12577979B2 · Microsoft Technology Licensing, LLC · Mar 17, 2026
A61K A61K
Grant

Antibodies Having Specificity To Her4 And Uses Thereof

US12577324B2 · INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) · Mar 17, 2026
A61K A61K
Grant

Diagnostic Antibodies Against Mucin 17 And Uses Thereof

US12577322B2 · AMGEN INC. · Mar 17, 2026
C07K G01N
Grant

Anti Bcma/Anti 4 1 Bb Bispecific Antibodies And Uses Thereof

US12577314B2 · ABL BIO INC. · Mar 17, 2026
C07K C07K
Grant

Anti Claudin 18.2 And Anti 4 1 Bb Bispecific Antibodies And Uses Thereof

US12577313B2 · I-Mab Biopharma US Limited · Mar 17, 2026
C07K C07K
Grant

Anti Csf1 R Molecules And Use Thereof

US12577309B2 · DRAGONBOAT BIOPHARMACEUTICAL (SHANGHAI) CO., LTD. · Mar 17, 2026
C07K C07K
Grant

Neutralizing Antibodies To Human Endothelin

US12577300B2 · Father Flanagan's Boys' Home Business · Mar 17, 2026
C07K C07K
Grant

Anti Il 27 Antibodies And Uses Thereof

US12577299B2 · SURFACE ONCOLOGY, LLC · Mar 17, 2026
A61P A61K
Grant

Ferritin Nanocage For Multi Displaying Trail Trimer And Cancer Targeting Peptide And Use Thereof As Anticancer Agent

US12577292B2 · KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION · Mar 17, 2026
C07K C07K
Grant

T Cell Receptors And Methods Of Use Thereof

US12577287B2 · University Health Network · Mar 17, 2026
C07K C07K
Grant

Mitochondrial Derived Peptides And Analogs Thereof For Use As A Therapy For Age Related Diseases Including Cancer

US12577281B2 · University of Southern California · Mar 17, 2026
C07K A61P
Grant

Influenza Virus Vaccines And Uses Thereof

US12577279B2 · Janssen Vaccines & Prevention B.V. · Mar 17, 2026
C07K A61K
Grant

Small Molecule Modulators Of Gut Bacterial Bile Acid Metabolism

US12577273B2 · President and Fellows of Harvard College · Mar 17, 2026
C07J C07J
Grant

Pyrimidine Compounds For Use As Map4 K1 Inhibitors

US12577267B2 · Glenmark Speciality S.A. · Mar 17, 2026
C07F C07F
Grant

Functionalized Gold Carbene Napthaquinone Complexes For Use In The Treatment Of Cancer

US12577262B2 · BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM · Mar 17, 2026
C07F C07F
Grant

Pcsk9 Antagonist Compounds

US12577259B2 · MERCK SHARP & DOHME LLC · Mar 17, 2026
C07D C07K
Grant

Heterocyclic Compounds

US12577257B2 · Hoffmann-La Roche Inc. · Mar 17, 2026
C07D C07D
Grant

Thienopyranones And Furanopyranones As Kinase, Bromodomain, And Checkpoint Inhibitors

US12577254B2 · Mar 17, 2026
C07D C07D
Grant

5,6 Dihydrothieno[3,4 H]Quinazoline Compound

US12577253B2 · SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL DEVELOPMENT CO., LTD. · Mar 17, 2026
C07D C07D
Grant

Drug For The Treatment Of Diseases Caused By Bacteria

US12577252B2 · Georgy Viktorovich Tets · Mar 17, 2026
A61K A61K
Grant

1,2,4 Triazolone Derivative As Dhodh Inhibitor, And Preparation Method Therefor And Use Thereof

US12577250B2 · WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD. · Mar 17, 2026
A61K A61K
Grant

Gcn2 And Perk Kinase Inhibitors And Methods Of Use Thereof

US12577249B2 · Deciphera Pharmaceuticals, LLC · Mar 17, 2026
C07D A61P
Grant

Diaminopyrazolo[1,5 A]Pyrimidine 6 Carbonitrile Compounds As Adenosine 2 A Receptor And Adenosine 2 B Receptor Antagonist

US12577247B2 · BUGWORKS RESEARCH, INC. · Mar 17, 2026
A61P A61K
Grant

Indoline Compound

US12577246B2 · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Mar 17, 2026
C07D C07D
Grant

Treatment Of Glaucoma With Rho Guanine Nucleotide Exchange Factor 12 (Arhgef12) Inhibitors

US12577562B2 · Regeneron Pharmaceuticals, Inc. · Mar 17, 2026
C12N C12N
Grant

Modified Neuraminidase

US12577570B2 · Tokushima University · Mar 17, 2026
C12N C12N
Grant

Engineered Botulinum Neurotoxin

US12577550B2 · President and Fellows of Harvard College · Mar 17, 2026
C12N C12N
Grant

Generation Of A Mesenchymal Stromal Cell Bank From The Pooled Mononuclear Cells Of Multiple Bone Marrow Donors

US12577535B2 · Johann Wolfgang Goethe-Universität, Frankfurt Am Main · Mar 17, 2026
C12N A61K
Grant

Transduction And Expansion Of Cells

US12577534B2 · IMPERIAL COLLEGE INNOVATIONS LIMITED · Mar 17, 2026
C12N C12N
Grant

Antiviral Heteroaryl Ketone Derivatives

US12577240B2 · Pfizer Inc. · Mar 17, 2026
C07D A61P
Grant

Androgen Receptor Protacs

US12577231B2 · GlaxoSmithKline Intellectual Property Development Limited · Mar 17, 2026
C07D C07D
Grant

Wdr5 Inhibitors And Modulators

US12577227B2 · Vanderbilt University · Mar 17, 2026
C07D C07D
Grant

Nuclear Transport Modulators And Uses Thereof

US12577225B2 · Karyopharm Therapeutics Inc. · Mar 17, 2026
A61K A61K
Grant

Phenethylamine Compounds Salts, Polymorphic Forms And Methods Of Use Thereof

US12577222B2 · Terran Biosciences Inc. · Mar 17, 2026
C07C C07C
Grant

Deuterated 1,4 Benzodiazepine 2,5 Dione Compound And Use Thereof

US12577213B2 · NINGBO COMBIREG PHARMACEUTICAL TECHNOLOGY CO., LTD. · Mar 17, 2026
C07D C07D
Grant

Pyrazolone Formyl Peptide 2 Receptor Agonists

US12577206B2 · Bristol-Myers Squibb Company · Mar 17, 2026
C07D C07D
Grant

Microbial Treatment For Water Systems And Soil Remediation

US12576435B2 · New Life Biosciences LLC · Mar 17, 2026
A01N A01N
Grant

Chimeric Antigen Receptor Factories And Methods Of Use Thereof

US12577311B2 · Dana-Farber Cancer Institute, Inc. · Mar 17, 2026
C07K C07K
Grant

Galectin 1/ Galectin 3 Chimeras And Multivalent Proteins

US12577282B2 · University of Florida Research Foundation, Incorporated · Mar 17, 2026
A61K A61P
Grant

Recombinant Proteins With Cd40 Activating Properties

US12576147B2 · INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) · Mar 17, 2026
A61K A61K
Grant

Method For Producing Reassortant Influenza Viruses

US12576146B2 · Seqirus UK Limited · Mar 17, 2026
C07K C12N
Grant

Crimean Congo Hemorrhagic Fever Virus M Segment Nucleic Acid Vaccine And Methods Of Use And Production

US12576145B2 · The Government of the United States, as Represented by the Secretary of the Army · Mar 17, 2026
A61K A61K
Grant

Cyclophilin 40 For Reduction Of Neurotoxic Fibrils And Treatment Of Neurodegenerative Diseases

US12576140B2 · UNIVERSITY OF SOUTH FLORIDA · Mar 17, 2026
A61K A61P
Grant

Method And Drug For Treating Spinal Muscular Atrophy

US12576139B2 · Talengen International Limited · Mar 17, 2026
A61K A61K
Grant

Compounds And Methods For The Immobilization Of Myostatin Inhibitors On The Extracellular Matrix By Transglutaminase

US12576138B2 · Julius-Maximilians-Universität Würzburg · Mar 17, 2026
A61K A61K
Grant

Crystalline Form Of Cxcr2 Antagonist And Application Thereof

US12577235B2 · SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY CO., LTD · Mar 17, 2026
C07D C07B
Grant

Compositions And Methods For Anti Tn Muc1 Gold Car T Cells

US12576135B2 · Mar 17, 2026
A61K A61K
Grant

Antiviral Lectin And Uses Thereof

US12576134B2 · ACADEMIA SINICA · Mar 17, 2026
A61K A61K
Grant

Altering Inflammatory States Of Immune Cells In Vivo By Modulating Cellular Activation States

US12576131B2 · Fred Hutchinson Cancer Center · Mar 17, 2026
A61K A61K
Grant

Dominant Negative Sarm1 Molecules Comprising A Substitution At Position 189, 190, 193, 194, 570 And/Or 685 Of Sarm1

US12576130B2 · Washington University · Mar 17, 2026
A61K A61K
Grant

Anthelmintic Compositions And Methods

US12576129B2 · UNIVERSITY OF MASSACHUSETTS · Mar 17, 2026
C12N C12N
Grant

Epitope Based Approach For Allergy Treatments And Inhibitors For Crohn's Disease

US12576123B2 · Psomagen, Inc. · Mar 17, 2026
A61K A61K
Grant

Combination Therapy For Cancer

US12576122B2 · UNITED ARAB EMIRATES UNIVERSITY · Mar 17, 2026
A61K A61K
Grant

Bacteriophages For The Treatment Of Tuberculosis

US12576118B2 · University of Pittsburgh—Of the Commonwealth System of Higher Education · Mar 17, 2026
A61K A61P
Grant

Antiviral Agent

US12576117B2 · TOHOKU UNIVERSITY · Mar 17, 2026
A61K A61K
Grant

Application Of Bmsc Exos In Treating Pd

US12576111B2 · NANTONG UNIVERSITY · Mar 17, 2026
A61K A61K
Grant

Dental Preparation Comprising Fibers Based On Hyaluronic Acid With Regulated Biodegradability

US12576104B2 · CONTIPRO A.S. · Mar 17, 2026
A61P A61P
Grant

Application Based Nucleotides Of Lactobacillus Rhamnosus To Prepare A Composition For Anti Lipogenesis

US12576101B2 · GenMont Biotech Incorporation · Mar 17, 2026
A61K A61K
Grant

Compositions Of Nitrates And Methods Of Use Thereof

US12576106B2 · HEARTBEET LTD. · Mar 17, 2026
A61K A61K
Grant

Anti Tumor Effective Component Of Hedyotis Diffusa, Preparation Method Therefor And Use Thereof

US12576097B2 · Guangdong New Ear Life Technology Co., Ltd. · Mar 17, 2026
A61K A61K
Grant

Combination Cannabinoid Phenylethanoid Formulation For Treatment Of Inflammation And Methods Related Thereto

US12576094B2 · Canole LLC · Mar 17, 2026
A61K A61K
Grant

Pharmaceutical Suspensions For Bismuth Subsalicylates

US12576092B2 · L. PERRIGO COMPANY · Mar 17, 2026
A61P A61P
Grant

Oral Brexanolone Compositions And Methods Of Preparation And Use

US12576090B1 · Mar 17, 2026
A61K A61P
Grant

Methods For Treating Testicular And Ovarian Adrenal Rest Tumors

US12576084B2 · SPRUCE BIOSCIENCES, INC. · Mar 17, 2026
A61K A61K
Grant

Mettl16 Inhibitors And Uses Thereof

US12576082B2 · CITY OF HOPE · Mar 17, 2026
A61K A61P
Grant

Methods And Compositions For Improving Exercise Performance, Single Ventricular Performance, Cardiac Output And Myocardial Performance Index (Mpi) In Single Ventricular Heart Disease, Using Udenafil Compositions

US12576081B2 · Mezzion Pharma Co., Ltd. · Mar 17, 2026
A61K A61K
Grant

Aryloxypiperidine Pyrazole Compounds As Indoleamine 2,3 Dioxygenase Inhibitors

US12576087B2 · Merck Sharp & Dohme LLC · Mar 17, 2026
A61K A61K
Grant

Methods For Treating Cholestasis

US12576079B2 · Mar 17, 2026
A61K A61K
Grant

Composition Of Radioactive And Non Radioactive Microparticles

US12576171B2 · ABK BIOMEDICAL INCORPORATED · Mar 17, 2026
A61K A61K
Grant

Rk Polypeptide Radiopharmaceutical Targeting Her2 And Preparation Method Thereof

US12576170B2 · Beijing Giluntide Pharmaceutical Co., Ltd. · Mar 17, 2026
A61K A61K
Grant

Contrast Agents For Detection Of Enzyme Activities Based On Melanin Synthesis

US12576166B2 · BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM · Mar 17, 2026
A61K A61K
Grant

Anti Human Pd 1 Antibody Crystals And Methods Of Use Thereof

US12576159B2 · Merck Sharp & Dohme LLC · Mar 17, 2026
C30B C07B
Grant

Conjugates Of Psma Binding Moieties With Cytotoxic Agents

US12576154B2 · PHILOCHEM AG · Mar 17, 2026
A61K A61K
Grant

Topical Composition

US12576152B2 · FUTURA MEDICAL DEVELOPMENTS LIMITED · Mar 17, 2026
A61P A61L
Grant

Methods For Enhancing Cytotoxic Cancer Therapy Through Inhibition Of Atg4 B

US12576088B2 · Northwestern University · Mar 17, 2026
A61K A61P
Grant

Use Of 2 [(3 Z) 6 Fluoro 2 Methyl 3 [(4 Methylsulfinylphenyl) Methylidenejinden 1 Yl] Acetic Acid

US12576053B2 · WYSZA SZKOA MEDYCZNA W BIAYMSTOKU · Mar 17, 2026
A61K A61P
Grant

Composition For Preventing, Alleviating Or Treating Cancer

US12576077B2 · CKP THERAPEUTICS, INC. · Mar 17, 2026
A61K A61K
Grant

Combination Therapies For Treating Cancer

US12576075B2 · INSTITUTE FOR CANCER RESEARCH · Mar 17, 2026
A61K A61K
Grant

Kits And Methods For Induction Of Cardioversion In Subjects With Atrial Arrhythmias

US12576074B2 · InCarda Therapeutics, Inc. · Mar 17, 2026
A61K A61K
Grant

Pharmaceutical Compositions

US12576071B2 · XSPRAY PHARMA AB · Mar 17, 2026
A61K A61K
Grant

Compositions Containing Amino Acids And Methods Of Using Such Compositions For Treating Sarcopenia

US12576068B2 · Societe des Produits Nestle S.A. · Mar 17, 2026
A61K A61K
Grant

Methods And Compositions For Treatment Of Mydriasis

US12576067B2 · Opus Genetics, Inc. · Mar 17, 2026
A61K A61K
Grant

Methods And Compositions For Treatment Of Mydriasis

US12576066B2 · Opus Genetics, Inc. · Mar 17, 2026
A61K A61K
Grant

Antibacterial And Biofilm Formation Inhibiting Composition Containing Myristoleic Acid As Active Ingredient

US12576057B2 · RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY · Mar 17, 2026
A61P A61P
Grant

Agent For Inducing Regression Of Triglyceride Deposit Atherosclerosis

US12576061B2 · OSAKA UNIVERSITY · Mar 17, 2026
A61K A61K
Grant

Medicine For Improving State Of Pregnancy, And Use Thereof

US12576070B2 · Koushi Yamaguchi · Mar 17, 2026
A61K A61P
Grant

Methods And Composition For Treating Respiratory Obstructive Diseases

US12576051B2 · The Regents of the University of California · Mar 17, 2026
A61K A61K
Grant

Dosage Regime

US12576050B2 · NOVABIOTICS LIMITED · Mar 17, 2026
A61K A61P
Grant

Anti Cancer Activity Of Adamantane Derivatives

US12576048B2 · The Regents of the University of California · Mar 17, 2026
A61K A61K
Grant

Telomerase Activating Compounds For Use In Fertility And Related Applications

US12576047B2 · Neuromagen Pharma Ltd · Mar 17, 2026
A61K A61K
Grant

Methods And Compositions For Treating Neurological Conditions

US12576042B2 · Mar 17, 2026
A61K A61P
Grant

Polymer Encapsulated Drug Particles

US12576037B2 · Tonic Medical, Inc. · Mar 17, 2026
A61K A61K
Grant

Formulations Of (+) 2 [1 (3 Ethoxy 4 Methoxy Phenyl) 2 Methanesulfonyl Ethyl] 4 Acetylaminoisoindoline 1,3 Dione

US12576034B2 · AMGEN INC. · Mar 17, 2026
A61K A61K
Grant

Compounds And Combinations Thereof For Treating Neurological And Psychiatric Conditions

US12576078B1 · ANTECIP BIOVENTURES II LLC · Mar 17, 2026
A61K A61K
Grant

Treatment Of Alzheimer's Disease

US12576044B2 · Mar 17, 2026
A61K A61K